» Articles » PMID: 36049666

TIGER: A Web Portal of Tumor Immunotherapy Gene Expression Resource

Overview
Specialty Biology
Date 2022 Sep 1
PMID 36049666
Authors
Affiliations
Soon will be listed here.
Abstract

Immunotherapy is a promising cancer treatment method; however, only a few patients benefit from it. The development of new immunotherapy strategies and effective biomarkers of response and resistance is urgently needed. Recently, high-throughput bulk and single-cell gene expression profiling technologies have generated valuable resources. However, these resources are not well organized and systematic analysis is difficult. Here, we present TIGER, a tumor immunotherapy gene expression resource, which contains bulk transcriptome data of 1508 tumor samples with clinical immunotherapy outcomes and 11,057 tumor/normal samples without clinical immunotherapy outcomes, as well as single-cell transcriptome data of 2,116,945 immune cells from 655 samples. TIGER provides many useful modules for analyzing collected and user-provided data. Using the resource in TIGER, we identified a tumor-enriched subset of CD4 T cells. Patients with melanoma with a higher signature score of this subset have a significantly better response and survival under immunotherapy. We believe that TIGER will be helpful in understanding anti-tumor immunity mechanisms and discovering effective biomarkers. TIGER is freely accessible at http://tiger.canceromics.org/.

Citing Articles

CSTF2-impeded innate αβ T cell infiltration and activation exacerbate immune evasion of pancreatic cancer.

He X, Liu J, Zhou Y, Zhao S, Chen Z, Xu Z Cell Death Differ. 2025; .

PMID: 39972059 DOI: 10.1038/s41418-025-01464-0.


Comprehensive exploration of programmed cell death landscape in lung adenocarcinoma combining multi-omic analysis and experimental verification.

Yu P, Xiao L, Hu K, Ling J, Chen Y, Liang R Sci Rep. 2025; 15(1):5364.

PMID: 39948103 PMC: 11825851. DOI: 10.1038/s41598-025-87982-w.


Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma.

Cheng Y, Chen X, Feng L, Yang Z, Xiao L, Xiang B Cell Discov. 2025; 11(1):1.

PMID: 39870619 PMC: 11772884. DOI: 10.1038/s41421-024-00747-z.


Selective deficiency of mitochondrial respiratory complex I subunits Ndufs4/6 causes tumor immunogenicity.

Liang J, Vitale T, Zhang X, Jackson T, Yu D, Jedrychowski M Nat Cancer. 2025; 6(2):323-337.

PMID: 39824999 DOI: 10.1038/s43018-024-00895-x.


Optimizing T cell inflamed signature through a combination biomarker approach for predicting immunotherapy response in NSCLC.

Chen Y, Chen A, Hong R, Huang B, Pirooznia M Sci Rep. 2024; 14(1):31382.

PMID: 39733163 PMC: 11682295. DOI: 10.1038/s41598-024-82903-9.


References
1.
Yost K, Satpathy A, Wells D, Qi Y, Wang C, Kageyama R . Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat Med. 2019; 25(8):1251-1259. PMC: 6689255. DOI: 10.1038/s41591-019-0522-3. View

2.
Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X . Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018; 24(10):1550-1558. PMC: 6487502. DOI: 10.1038/s41591-018-0136-1. View

3.
Weinstein J, Collisson E, Mills G, Mills Shaw K, Ozenberger B, Ellrott K . The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013; 45(10):1113-20. PMC: 3919969. DOI: 10.1038/ng.2764. View

4.
Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck 3rd W . Comprehensive Integration of Single-Cell Data. Cell. 2019; 177(7):1888-1902.e21. PMC: 6687398. DOI: 10.1016/j.cell.2019.05.031. View

5.
Efremova M, Vento-Tormo M, Teichmann S, Vento-Tormo R . CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat Protoc. 2020; 15(4):1484-1506. DOI: 10.1038/s41596-020-0292-x. View